Wells Fargo & Company Harmony Biosciences Holdings, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 16,768 shares of HRMY stock, worth $585,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,768

Previous 16,745 0.14%

Holding current value

$585,370

Previous $562,000 10.14%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$28.81 - $33.01 $662 - $759	23 Added 0.14%	16,768 $505,000
Q1 2024 May 10, 2024	BUY	$29.93 - $35.06 $37,921 - $44,421	1,267 Added 8.19%	16,745 $562,000
Q4 2023 Feb 09, 2024	BUY	$19.2 - $33.78 $10,425 - $18,342	543 Added 3.64%	15,478 $499,000
Q3 2023 Nov 13, 2023	SELL	$31.89 - $39.03 $860,998 - $1.05 Million	-26,999 Reduced 64.38%	14,935 $489,000
Q2 2023 Aug 15, 2023	BUY	$30.5 - $37.4 $221,491 - $271,598	7,262 Added 20.94%	41,934 $1.48 Million
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $302,794 - $530,087	9,831 Added 39.58%	34,672 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $655,848 - $879,905	14,446 Added 138.97%	24,841 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $181,152 - $238,823	-4,307 Reduced 29.3%	10,395 $460,000
Q2 2022 Aug 12, 2022	SELL	$33.54 - $52.15 $76,773 - $119,371	-2,289 Reduced 13.47%	14,702 $717,000
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $247,820 - $382,350	-7,478 Reduced 30.56%	16,991 $827,000
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $1.97 Million - $2.53 Million	-57,675 Reduced 70.21%	24,469 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $1.86 Million - $2.79 Million	72,383 Added 741.55%	82,144 $3.15 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $74,167 - $95,538	2,857 Added 41.38%	9,761 $276,000
Q1 2021 May 13, 2021	SELL	$27.56 - $40.37 $725,158 - $1.06 Million	-26,312 Reduced 79.21%	6,904 $228,000
Q4 2020 Feb 09, 2021	BUY	$31.74 - $51.34 $1.02 Million - $1.65 Million	32,216 Added 3221.6%	33,216 $1.2 Million
Q3 2020 Nov 05, 2020	BUY	$30.96 - $44.39 $30,960 - $44,390	1,000 New	1,000 $34,000

Others Institutions Holding HRMY

# of Institutions

233

Shares Held

45.2M

Call Options Held

48.2K

Put Options Held

56.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.07B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Harmony Biosciences Holdings, Inc. Transaction History